Nitric oxide and beyond: new insights and therapies for pulmonary hypertension
Author:
Open Access
- 5 December 2008
- journal article
- review article
- Published by Springer Nature in Journal of Perinatology
- Vol. 28 (S3) , S67-S71
Abstract
Persistent pulmonary hypertension of the newborn (PPHN) contributes significantly to the morbidity and mortality associated with meconium aspiration syndrome. This review article discusses new insights into the vascular abnormalities that are associated with PPHN, including the recent recognition of the importance of oxidant stress in its pathogenesis. Recent data are presented showing that treatment with high oxygen concentrations may increase production of oxygen free radicals. The rationale for the use of inhaled nitric oxide, and strategies for enhancing nitric oxide signaling are discussed. Finally, the rationale for new treatment approaches is reviewed, including inhibition of cyclic guanosine monophosphate-specific phosphodiesterases and scavengers of reactive oxygen species.Keywords
This publication has 25 references indexed in Scilit:
- Pulmonary Hemodynamics in Neonatal Lambs Resuscitated with 21%, 50%, and 100% OxygenPediatric Research, 2007
- Early Inhaled Nitric Oxide Therapy for Term and Near-Term Newborn Infants with Hypoxic Respiratory Failure: Neurodevelopmental Follow-UpThe Journal of Pediatrics, 2007
- Superoxide Dismutase Improves Oxygenation and Reduces Oxidation in Neonatal Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newbornJournal of Critical Care, 2006
- Neonatal extracorporeal life support: Impact of new therapies on survivalThe Journal of Pediatrics, 2006
- Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded StudyPediatrics, 2006
- Pulmonary Arterial Contractility in Neonatal Lambs Increases with 100% Oxygen ResuscitationPediatric Research, 2006
- Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheepAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- The diseases treated with ECMO: Focus on PPHNSeminars in Perinatology, 2005
- Sildenafil Ameliorates Effects of Inhaled Nitric Oxide WithdrawalAnesthesiology, 1999